InvestorsHub Logo
Followers 42
Posts 2198
Boards Moderated 0
Alias Born 02/10/2014

Re: None

Thursday, 07/16/2015 10:17:38 AM

Thursday, July 16, 2015 10:17:38 AM

Post# of 2206
UniQure and Huntington's...posted by Drafter at Hotcopper site....



Uniqure just appointed a lead to their CNS programs, which includes the Benitec licenced Huntington's programme.


AMSTERDAM, the Netherlands, July 16, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that Charles W. Richard, M.D., Ph.D., has been hired as Senior Vice President, Research and Development, Neuroscience, to lead the Company's growing portfolio of gene therapies targeting neurological diseases including current clinical trials for the treatment of Sanfilippo B syndrome and Parkinson's disease as well as preclinical programs in Huntington's disease and other rare CNS disorders. Dr. Richard will report to Jörn Aldag, Chief Executive Officer of uniQure, and be based in the Company's Lexington, Massachusetts facility.

All my posts, comments, and investments are not to be considered investment advice in any way.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News